Seven patents currently held, every record listed here
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Jul 2031. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Jul 2031
Next term end
3
Patent families
When these terms end
Each bar runs from grant to computed term end. 2018 to 2042.
US 9,938,501
Encapsulated Adipose-Derived Stem Cells, Methods for Preparation and Theraputic Use
Jul 28, 2031
US 11,447,748
Encapsulated Adipose-Derived Stem Cells, Methods for Preparation and Theraputic Use
Oct 14, 2031
US 10,745,666
Encapsulated Adipose-Derived Stem Cells, Methods for Preparation and Therapeutic Use
Jun 4, 2032
20232028203320382042
1 pending application: term is not computable until grant.Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jul 2032 · High confidence
Also notable
Ends Jun 2042 · High confidence
Also notable
Ends Jun 2032 · High confidence
System and Methods for Preparation of Adipose-Derived Stem Cells
US 9,931,445
The most cited patent in this portfolio, cited by 34 later US patents, top 10% of utility patents granted in 2018 in our data. Protection runs to 2032.
System and Methods for Preparation of Adipose-Derived Stem Cells
US 11,766,459
Cited by 5 later US patents, top 25% of utility patents granted in 2023 in our data. Protection runs to 2042.
Encapsulated Adipose-Derived Stem Cells, Methods for Preparation and Therapeutic Use
US 10,745,666
Granted 2020. Computed term ends 2032.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Mar 26, 2027The maintenance fee for System and Methods for Preparation of Adipose-Derived Stem Cells (US 11,766,459) comes due Mar 26, 2027. Unpaid by Sep 27, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
| Encapsulated Adipose-Derived Stem Cells, Methods for Preparation and Theraputic Use | 3 in force | to Jun 2032 |
| System and Methods for Preparation of Adipose-Derived Stem Cells (2019) | 2 in force | to Jun 2042 |
| System and Methods for Preparation of Adipose-Derived Stem Cells (2012) | 2 in force | to Jul 2032 |
Patents held now
Soonest term end first.
Showing 1 to 7 of 7
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,938,501 | Encapsulated Adipose-Derived Stem Cells, Methods for Preparation and Theraputic Use In force · High confidence | In force | High confidence | |
| US 11,447,748 | Encapsulated Adipose-Derived Stem Cells, Methods for Preparation and Theraputic Use In force · High confidence | In force | High confidence | |
| US 10,745,666 | Encapsulated Adipose-Derived Stem Cells, Methods for Preparation and Therapeutic Use In force · High confidence | In force | High confidence | |
| US 9,931,445 | System and Methods for Preparation of Adipose-Derived Stem Cells In force · High confidence | In force | High confidence | |
| US 10,967,110 | System and Methods for Preparation of Adipose-Derived Stem Cells In force · High confidence | In force | High confidence | |
| US 12,239,669 | System and Methods for Preparation of Adipose-Derived Stem Cells In force · Medium confidence | In force | Medium confidence | |
| US 11,766,459 | System and Methods for Preparation of Adipose-Derived Stem Cells In force · High confidence | In force | High confidence |
Also on record, not counted in the 7: 1 application pending · 1 application abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.